Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Duterte says Filipinos can use Pfizer vaccine, but touts Sinovac deal

Published 01/19/2021, 01:53 AM
Updated 01/19/2021, 02:00 AM
© Reuters.
AZN
-
NVAX
-
SVA
-
MRNA
-
BNTX
-

MANILA, Jan 18 (Reuters) - Philippine President Rodrigo
Duterte said on Monday he would not stop Filipinos from getting
shots of the COVID-19 vaccine made by Pfizer PFE.N and
BioNTech BNTX.O , despite reports in Norway of deaths among
frail elderly people after being inoculated.
"Almost everybody that I know (is) scrambling to buy this
Pfizer (vaccine). To me I think it's a good one," he said in a
late-night televised address. "If you want to follow the
experience of Norway, go ahead. Nobody would stop you."
Norway said on Monday it was not changing its policy on the
use of the Pfizer and BioNTech vaccine following reports of
deaths among very frail recipients after the inoculation was
given. In his address, Duterte also reiterated his defense of the
government's supply deals involving CoronaVac, the vaccine
developed by China's Sinovac Biotech SVA.O .
The Philippines' Food and Drug Administration (FDA) has
authorised the emergency use of Pfizer's vaccine, the first to
be approved in the Southeast Asian country, which has one of the
highest numbers of coronavirus cases in Asia. The government aims to begin immunization next month, hoping
to inoculate 70 million people, or two-thirds of its population,
this year.
Duterte said Sinovac's vaccine is now being used in
Thailand, Malaysia, Indonesia, Turkey, Egypt, United Arab
Emirates, and Brazil, and there have been no deaths reported so
far.
The Philippines has also firmed up supply deals with Novavax
NVAX.O , Moderna MRNA.O , AstraZeneca AZN.L , Johnson &
Johnson JNJ.N , and Russia's Gamaleya Institute, according to
Carlito Galvez, a former military chief who handles the
government's vaccine procurement.
Duterte assured the public of corruption-free vaccine supply
deals, after the Senate launched an inquiry into government
transactions amid questions about pricing transparency and
efficacy.
"I'm telling now General Galvez to proceed with his game
plan, with or without the investigation", which he said could
derail the government's vaccination plan.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.